Scientific article
Case report
English

Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option

Published in

Veterinary and human toxicology, vol. 43, no. 2, p. 99-102

Publication date

2001

Abstract

Severe adverse effects due to 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are reported with increasing frequency in the medical literature. The signs of acute toxicity most often seen are fulminant hyperthermia, hyperexcitatory states, acute renal failure and hyponatraemia. In 1992, hepatotoxicity was also described with unexplained jaundice and hepatomegaly after ingestion of MDMA. We report a case of severe toxic hepatitis following ingestion of MDMA with fulminant hepatic failure which required auxiliary liver transplantation. The diagnosis was necrotic toxic hepatitis following ecstasy ingestion. The outcome was successful, and the patient was discharged from ICU 20 d after surgery. Hepatotoxic effects of MDMA seem infrequent, but may be lethal; liver transplantation is the ultimate therapeutic option in some cases.

Keywords

  • Adult
  • Hallucinogens/adverse effects
  • Humans
  • Liver Failure/chemically induced/therapy
  • Liver Transplantation
  • Male
  • N-Methyl-3,4-methylenedioxyamphetamine/adverse effects
  • Street Drugs/adverse effects

Citation (ISO format)

GARBINO, Jorge et al. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option. In: Veterinary and human toxicology, 2001, vol. 43, n° 2, p. 99–102. doi: 10.1016/s1098-3597(01)90081-x

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0145-6296
637views
0downloads

Technical informations

Creation

04/06/2014 14:40:00

First validation

04/06/2014 14:40:00

Update

14/03/2023 21:23:44

Status update

14/03/2023 21:23:43

Last indexation

30/10/2024 19:12:08
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated